Last Updated: July 01, 2024
ibsa-pharma.de has 2 NS records, 3 A records, 0 AAAA records, 0 MX records, and 1 TXT records. Name servers for ibsa-pharma.de are lennon.ns.cloudflare.com, blakely.ns.cloudflare.com. A records for ibsa-pharma.de are , 45.223.167.12, 45.223.179.12. We have observed ibsa-pharma.de to have 1 subdomains. A subdomain count of 1 is considered a small digital footprint. Technology that may be in use at ibsa-pharma.de includes globalsign. The website's description is: "ibsa ist ein multinationales schweizer pharmaunternehmen mit hauptsitz in lugano, schweiz."
Search DigitalStakeout ASI to find another asset.
No DNS A records
No DNS AAAA records
No DNS MX records
lennon.ns.cloudflare.com
blakely.ns.cloudflare.com
ibsa-pharma.de. 300 IN TXT "globalsign-domain-verification=3E8937162E283AA249E049DA4E22346E"
ibsa-pharma.de has 1 subdomains in our inventory.
45.223.167.12
og:locale: de
og:title: home
og:type: article
og:url: https://www.ibsa-pharma.de/
og:image: https://www.ibsa-pharma.de/dam/jcr:ef38b1fc-cebb-4e2c-8c22-c861fccfe09f/desk-img-1200x630.jpg
og:image:secure_url: https://www.ibsa-pharma.de/dam/jcr:ef38b1fc-cebb-4e2c-8c22-c861fccfe09f/desk-img-1200x630.jpg
og:image:width: 1200
og:image:height: 627
og:site_name: site-ibsa-germany
og:description: ibsa ist ein multinationales schweizer pharmaunternehmen mit hauptsitz in lugano, schweiz.
{"data":{"cert_index":878834931,"cert_link":"https:\/\/ct.googleapis.com\/logs\/eu1\/xenon2024\/ct\/v1\/get-entries?start=878834931&end=878834931","leaf_cert":{"all_domains":["*.ibsa-pharma.de","imperva.com"],"extensions":{"authorityInfoAccess":"CA Issuers - URI:http:\/\/secure.globalsign.com\/cacert\/gsatlasr3dvtlsca2024q1.crt\nOCSP - URI:http:\/\/ocsp.globalsign.com\/ca\/gsatlasr3dvtlsca2024q1\n","authorityKeyIdentifier":"keyid:66:C0:C7:A3:9A:CD:FE:F3:EA:CE:4B:53:0B:61:5E:AF:33:05:B3:E1\n","basicConstraints":"CA:FALSE","certificatePolicies":"Policy: 1.3.6.1.4.1.4146.10.1.3\n CPS: https:\/\/www.globalsign.com\/repository\/","crlDistributionPoints":"Full Name:\n URI:http:\/\/crl.globalsign.com\/ca\/gsatlasr3dvtlsca2024q1.crl","ctlPoisonByte":true,"extendedKeyUsage":"TLS Web server authentication, TLS Web client authentication","keyUsage":"Digital Signature, Key Encipherment","subjectAltName":"DNS:imperva.com, DNS:*.ibsa-pharma.de","subjectKeyIdentifier":"51:53:12:AA:F6:69:9E:BE:20:07:AD:3C:BF:C2:0A:D2:CC:D7:BE:2B"},"fingerprint":"0A:8C:A3:0E:9B:87:B9:91:E3:01:57:CB:87:72:8D:D8:19:7B:D8:1A","issuer":{"C":"BE","CN":"GlobalSign Atlas R3 DV TLS CA 2024 Q1","L":null,"O":"GlobalSign nv-sa","OU":null,"ST":null,"aggregated":"\/C=BE\/CN=GlobalSign Atlas R3 DV TLS CA 2024 Q1\/O=GlobalSign nv-sa","emailAddress":null},"not_after":1704990961,"not_before":1704904561,"serial_number":"1A8F71BEE40CD54BCFC124EBAE38574","signature_algorithm":"sha256, rsa","subject":{"C":null,"CN":"imperva.com","L":null,"O":null,"OU":null,"ST":null,"aggregated":"\/CN=imperva.com","emailAddress":null}},"seen":1704904711.400051,"source":{"name":"Google 'Xenon2024' log","url":"https:\/\/ct.googleapis.com\/logs\/eu1\/xenon2024\/"},"update_type":"PrecertLogEntry"},"message_type":"certificate_update"}